Difference between revisions of "Ultrasound CEUS BC"
Jump to navigation
Jump to search
Line 19: | Line 19: | ||
'''Approved Call Summaries:''' | '''Approved Call Summaries:''' | ||
− | *[[Media: | + | *[[Media:12 09 2022 QIBA CEUS BC Call Summary-FINAL.pdf|December 9, 2022]] |
− | *No | + | *No calls in October or November |
*[[Media:09 09 2022 QIBA CEUS BC Call Summary-FINAL.pdf|September 9, 2022]] | *[[Media:09 09 2022 QIBA CEUS BC Call Summary-FINAL.pdf|September 9, 2022]] | ||
*[[Media:08 12 2022 QIBA CEUS BC Call Summary-FINAL-2.pdf|August 12, 2022]] | *[[Media:08 12 2022 QIBA CEUS BC Call Summary-FINAL-2.pdf|August 12, 2022]] |
Revision as of 22:06, 12 December 2022
- Co-chairs: Michalakis (Mike) A. Averkiou, PhD; Richard G. Barr, MD, PhD; Todd Erpelding, PhD, MSE
- RSNA Staff Support: Julie Lisiecki
Project Snapshot
The Contrast Enhanced Ultrasound Biomarker Committee (CEUS BC) seeks to develop a quantitative imaging profile for CEUS imaging.
Project Descriptions:
CEUS Biomarker Committee Proposal:
Recent Meetings
Approved Call Summaries:
- December 9, 2022
- No calls in October or November
- September 9, 2022
- August 12, 2022
- July 15, 2022
- June 10, 2022
- May 13, 2022
- March 11, 2022
- February 11, 2022
- January 14, 2022
CEUS Task Force (TF) Call Summaries
Working Documents
Statistical Reference Documents
Workflow Documents
Historical Background - Formation of the Group
Reference Materials
Original Proposal to the QIBA Steering Committee:
Vendor Press Release:
Presentations: